
Accuray Incorporated ARAY
$ 0.31
-7.0%
Quarterly report 2026-Q3
added 05-06-2026
Accuray Incorporated Cash and Cash Equivalents 2011-2026 | ARAY
Annual Cash and Cash Equivalents Accuray Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 57.4 M | 68.6 M | 89.4 M | 88.7 M | 118 M | 110 M | 76.8 M | 83.1 M | 72.1 M | 120 M | 79.6 M | 92.3 M | 73.3 M | 144 M | 95.9 M | 45.4 M | 36.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 144 M | 36.8 M | 85.3 M |
Quarterly Cash and Cash Equivalents Accuray Incorporated
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 38.1 M | 41.3 M | 63.3 M | 41.3 M | 63.3 M | 57.4 M | 77.8 M | 62.6 M | 61.1 M | 68.6 M | 62.2 M | 74.5 M | 78.7 M | 89.4 M | 90.8 M | 69.2 M | 82.4 M | 88.7 M | 99.3 M | 125 M | 106 M | 118 M | 116 M | 107 M | 90 M | 108 M | 108 M | 96.4 M | 80.9 M | 76.8 M | 76.8 M | 59.4 M | 68.5 M | 83.1 M | 83.1 M | 79.5 M | 67.9 M | 72.1 M | 72.1 M | 69.5 M | 83.6 M | 120 M | 120 M | 88.5 M | 85.6 M | 88.5 M | 85.6 M | 97.3 M | 107 M | 97.3 M | 107 M | 70.4 M | 62.4 M | 70.4 M | 62.4 M | 94.8 M | 122 M | 94.8 M | 122 M | 148 M | 140 M | 148 M | 140 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 148 M | 38.1 M | 87.8 M |
Cash and Cash Equivalents of other stocks in the Medical devices industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Avinger
AVGR
|
5.28 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
105 M | - | - | $ 3.31 B | ||
|
Allied Healthcare Products
AHPI
|
3.32 M | - | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
45.9 M | $ 11.65 | 4.01 % | $ 330 M | ||
|
Apollo Endosurgery
APEN
|
57 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
161 M | $ 8.17 | -0.85 % | $ 1.23 B | ||
|
Aziyo Biologics
AZYO
|
36.4 M | - | 1.37 % | $ 20.5 M | ||
|
EDAP TMS S.A.
EDAP
|
29.8 M | $ 4.46 | 4.94 % | $ 167 M | ||
|
BioSig Technologies
BSGM
|
20.3 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
6.57 M | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
48.7 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
66.4 M | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
7.28 M | $ 2.31 | - | $ 50.9 M | ||
|
Cytosorbents Corporation
CTSO
|
6.25 M | $ 0.44 | -5.32 % | $ 27.4 M | ||
|
OrthoPediatrics Corp.
KIDS
|
19.6 M | $ 18.27 | -1.24 % | $ 429 M | ||
|
Delcath Systems
DCTH
|
43.5 M | $ 11.44 | 1.87 % | $ 410 M | ||
|
LivaNova PLC
LIVN
|
636 M | $ 73.67 | -0.05 % | $ 4.02 B | ||
|
LENSAR
LNSR
|
13 M | $ 5.98 | 1.7 % | $ 71.5 M | ||
|
Neovasc
NVCN
|
51.5 M | - | - | $ 111 M | ||
|
IRIDEX Corporation
IRIX
|
6.03 M | $ 1.01 | 1.0 % | $ 17.1 M | ||
|
Dynatronics Corporation
DYNT
|
326 K | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
101 M | - | - | $ 10.2 M | ||
|
MiMedx Group
MDXG
|
166 M | $ 3.63 | -4.12 % | $ 536 M | ||
|
Pulmonx Corporation
LUNG
|
69.8 M | $ 1.54 | -0.32 % | $ 62.7 M | ||
|
Electromed
ELMD
|
15.3 M | $ 38.72 | 2.6 % | $ 327 M | ||
|
Myomo
MYO
|
14.1 M | $ 0.94 | 3.35 % | $ 39.3 M | ||
|
Butterfly Network
BFLY
|
150 M | $ 4.5 | 2.39 % | $ 1.11 B | ||
|
Second Sight Medical Products
EYES
|
16.2 M | - | -0.97 % | $ 54.4 M | ||
|
Orthofix Medical
OFIX
|
82 M | $ 9.55 | -21.4 % | $ 378 M | ||
|
GBS
GBS
|
1.02 M | - | -0.57 % | $ 7.12 M | ||
|
Profound Medical Corp.
PROF
|
59.7 M | $ 6.93 | 0.14 % | $ 210 M | ||
|
Globus Medical
GMED
|
526 M | $ 84.09 | 0.1 % | $ 11.4 B | ||
|
Insulet Corporation
PODD
|
716 M | $ 157.27 | 0.43 % | $ 11.1 B | ||
|
CONMED Corporation
CNMD
|
40.8 M | $ 37.23 | 0.55 % | $ 1.16 B | ||
|
Inspire Medical Systems
INSP
|
105 M | $ 44.48 | 0.75 % | $ 1.31 B | ||
|
Sintx Technologies
SINT
|
4.14 M | $ 2.22 | 0.45 % | $ 6.16 M | ||
|
Integer Holdings Corporation
ITGR
|
17.2 M | $ 90.02 | -1.54 % | $ 3.13 B | ||
|
Invacare Corporation
IVC
|
58.8 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
2.94 B | $ 83.23 | 0.29 % | $ 48.7 B | ||
|
Stryker Corporation
SYK
|
4.01 B | $ 315.42 | -1.88 % | $ 121 B |